Released Jan 29, 2015, after the close
10-K filed Jan 29, 2015, 90 days after period end · 0001354488-15-000359
Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$826.87K$826.87K derived−32.2% vs Q4 2013+38.5% vs Q3 2014
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$2,332,859−26.3%
Operating Incomederived$919,006−38.7%
Operating Cash Flowderived$1,365,553−54.1%
Free Cash Flowderived$1,329,866−54.6%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Net Income | $826.87K | $1.22M | $1.08M | $824.43K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR